BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 34571027)

  • 1. An Enhancer-Driven Stem Cell-Like Program Mediated by SOX9 Blocks Intestinal Differentiation in Colorectal Cancer.
    Liang X; Duronio GN; Yang Y; Bala P; Hebbar P; Spisak S; Sahgal P; Singh H; Zhang Y; Xie Y; Cejas P; Long HW; Bass AJ; Sethi NS
    Gastroenterology; 2022 Jan; 162(1):209-222. PubMed ID: 34571027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX9-activated FARSA-AS1 predetermines cell growth, stemness, and metastasis in colorectal cancer through upregulating FARSA and SOX9.
    Zhou T; Wu L; Ma N; Tang F; Yu Z; Jiang Z; Li Y; Zong Z; Hu K
    Cell Death Dis; 2020 Dec; 11(12):1071. PubMed ID: 33318478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer.
    Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P
    Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor γ-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer.
    Panza A; Votino C; Gentile A; Valvano MR; Colangelo T; Pancione M; Micale L; Merla G; Andriulli A; Sabatino L; Vinciguerra M; Prattichizzo C; Mazzoccoli G; Colantuoni V; Piepoli A
    Biochim Biophys Acta; 2014 Jun; 1843(6):1225-36. PubMed ID: 24631504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX9 is an atypical intestinal tumor suppressor controlling the oncogenic Wnt/ß-catenin signaling.
    Prévostel C; Rammah-Bouazza C; Trauchessec H; Canterel-Thouennon L; Busson M; Ychou M; Blache P
    Oncotarget; 2016 Dec; 7(50):82228-82243. PubMed ID: 27429045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Claudin-7 deficiency promotes stemness properties in colorectal cancer through Sox9-mediated Wnt/β-catenin signalling.
    Xu C; Ding YH; Wang K; Hao M; Li H; Ding L
    J Transl Med; 2021 Jul; 19(1):311. PubMed ID: 34281572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZRANB1 enhances stem-cell-like features and accelerates tumor progression by regulating Sox9-mediated USP22/Wnt/β-catenin pathway in colorectal cancer.
    Miao D; Wang Y; Jia Y; Tong J; Jiang S; Liu L
    Cell Signal; 2022 Feb; 90():110200. PubMed ID: 34798260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
    Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
    Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serine-threonine Kinase Receptor-Associated Protein is a Critical Mediator of APC Mutation-Induced Intestinal Tumorigenesis Through a Feed-Forward Mechanism.
    Vu T; Datta A; Banister C; Jin L; Yuan G; Samuel T; Bae S; Eltoum IE; Manne U; Zhang B; Welner RS; Mitra K; Buckhaults P; Datta PK
    Gastroenterology; 2022 Jan; 162(1):193-208. PubMed ID: 34520730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells.
    Hwang WL; Yang MH; Tsai ML; Lan HY; Su SH; Chang SC; Teng HW; Yang SH; Lan YT; Chiou SH; Wang HW
    Gastroenterology; 2011 Jul; 141(1):279-91, 291.e1-5. PubMed ID: 21640118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dose-dependent effect of SOX9 and its incidence in colorectal cancer.
    Prévostel C; Blache P
    Eur J Cancer; 2017 Nov; 86():150-157. PubMed ID: 28988015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay between SOX9, β-catenin and PPARγ activation in colorectal cancer.
    Panza A; Pazienza V; Ripoli M; Benegiamo G; Gentile A; Valvano MR; Augello B; Merla G; Prattichizzo C; Tavano F; Ranieri E; di Sebastiano P; Vinciguerra M; Andriulli A; Mazzoccoli G; Piepoli A
    Biochim Biophys Acta; 2013 Aug; 1833(8):1853-65. PubMed ID: 23583560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Troy, a tumor necrosis factor receptor family member, interacts with lgr5 to inhibit wnt signaling in intestinal stem cells.
    Fafilek B; Krausova M; Vojtechova M; Pospichalova V; Tumova L; Sloncova E; Huranova M; Stancikova J; Hlavata A; Svec J; Sedlacek R; Luksan O; Oliverius M; Voska L; Jirsa M; Paces J; Kolar M; Krivjanska M; Klimesova K; Tlaskalova-Hogenova H; Korinek V
    Gastroenterology; 2013 Feb; 144(2):381-391. PubMed ID: 23142137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorquinaldol targets the β-catenin and T-cell factor 4 complex and exerts anti-colorectal cancer activity.
    Wang L; Deng K; Gong L; Zhou L; Sayed S; Li H; Sun Q; Su Z; Wang Z; Liu S; Zhu H; Song J; Lu D
    Pharmacol Res; 2020 Sep; 159():104955. PubMed ID: 32485279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sox9 transcriptionally regulates Wnt signaling in intestinal epithelial stem cells in hypomethylated crypts in the diabetic state.
    Huang CZ; Xu JH; Zhong W; Xia ZS; Wang SY; Cheng D; Li JY; Wu TF; Chen QK; Yu T
    Stem Cell Res Ther; 2017 Mar; 8(1):60. PubMed ID: 28279198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H3K79me2/3 controls enhancer-promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells.
    Godfrey L; Crump NT; O'Byrne S; Lau IJ; Rice S; Harman JR; Jackson T; Elliott N; Buck G; Connor C; Thorne R; Knapp DJHF; Heidenreich O; Vyas P; Menendez P; Inglott S; Ancliff P; Geng H; Roberts I; Roy A; Milne TA
    Leukemia; 2021 Jan; 35(1):90-106. PubMed ID: 32242051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.
    Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C
    Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.